ByTrending Posts
Innovent and Eli Lilly Expand Strategic Alliance to…
Shanghai, China – February, 2026 – Innovent Biologics Inc today announced a new strategic collaboration with Eli Lilly…
Eli Lilly to Acquire Orna Therapeutics in Deal…
Indianapolis, IN – February 9, 2026 – Eli Lilly and Company today announced it has entered into a…
AstraZeneca Reports 2025 Performance with Strong Brand Momentum…
AstraZeneca today announced its full-year 2025 results, reflecting continued growth across oncology, cardiovascular-renal-metabolism (CVRM), respiratory & immunology, and…
GSK Reports Full-Year 2025 Results with Strategic Portfolio…
GSK today reported its full-year performance for 2025 and outlined its strategic approach to long-term growth across vaccines,…
Roche Reports Full-Year 2025 Results and Provides Strategic…
Roche today announced its full-year 2025 performance and outlined its strategic positioning across key therapeutic areas. Roche maintained…
Top 10 Pharma Brands of 2025 — Sales…
The pharmaceutical market in 2025 was defined by high-value specialty brands delivering breakthrough outcomes in oncology, metabolic disease,…
Big Pharma Accelerates Shift to Off-the-Shelf Cell Therapy…
The global biopharmaceutical industry is entering a new phase in cell therapy innovation, marked by significant investments in…
Drugmakers Use AI to Speed Trials and Regulatory…
Pharmaceutical companies are increasingly using artificial intelligence to streamline clinical trials and regulatory filings. While AI has not…
AI Is Reshaping Pharma’s Economics—But Discovery Isn’t the…
Executive Summary Artificial intelligence has moved from experimental promise to operational backbone across global biopharma. Industry leaders including…
Trending Posts
Latest Stories
Biotech Licensing Soars to $137B in 2025 – China Now Leads the Licensing Race
The global biotech licensing market hit a record $137 billion in 2025, and 2026 is…
China Dominates 70% of Global AI Drug Patents: ADC/Bispecifics Surge or Innovation Bubble?
China Leads 70% of Global AI Drug Patents: Simple Strategic Snapshot China now holds 70%…
Merck’s First Fully AI-Designed Oncology Drug: 2027 China Approval Nears or Hype Peaks?
Merck’s January 26–March 2026 trajectory signals China will approve its first fully AI-designed compound by…
Tsinghua’s Agent Hospital Pilots: World’s First AI Hospital or Closed Data Experiment?
Tsinghua University’s “world’s first AI Hospital” advanced public pilots February 28-March 2, 2026—deploying 42 AI…
Gallery
